Rockwell Medical's Triferic Receives Permanent J-Code for Renal Drug Reimbursement
November 30, 2015 at 08:02 AM EST
Rockwell Medical, Inc. (NASDAQ: RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic ...